Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1525 to 1530 of 1530 entries
Sorted by: Best Match Show Resources per page
Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms.

Urology

Greenberg DR, Sohlberg EM, Zhang CA, Santini VE, Comiter CV, Enemchukwu EA.
PMID: 32681915
Urology. 2020 Oct;144:99-105. doi: 10.1016/j.urology.2020.06.063. Epub 2020 Jul 15.

OBJECTIVE: To assess the efficacy, safety, and outcomes of sacral nerve stimulation (SNS) for Parkinson's disease (PD) patients with overactive bladder symptoms.METHODS: We retrospectively reviewed PD patients who underwent Stage I SNS. Demographics, urodynamic data, and baseline voiding function...

Cite
Greenberg DR, Sohlberg EM, Zhang CA, et al. Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms. Urology. 2020;144:99-105doi: 10.1016/j.urology.2020.06.063.
Greenberg, D. R., Sohlberg, E. M., Zhang, C. A., Santini, V. E., Comiter, C. V., & Enemchukwu, E. A. (2020). Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms. Urology, 14499-105. https://doi.org/10.1016/j.urology.2020.06.063
Greenberg, Daniel R, et al. "Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms." Urology vol. 144 (2020): 99-105. doi: https://doi.org/10.1016/j.urology.2020.06.063
Greenberg DR, Sohlberg EM, Zhang CA, Santini VE, Comiter CV, Enemchukwu EA. Sacral Nerve Stimulation in Parkinson's Disease Patients With Overactive Bladder Symptoms. Urology. 2020 Oct;144:99-105. doi: 10.1016/j.urology.2020.06.063. Epub 2020 Jul 15. PMID: 32681915.
Copy Download .nbib Format: NLM
Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan.

Frontiers in pediatrics

Hoshino K, Hayashi M, Ishizaki A, Kimura K, Kubota M, Nezu A, Yasuhara A.
PMID: 33748036
Front Pediatr. 2021 Mar 04;9:569594. doi: 10.3389/fped.2021.569594. eCollection 2021.

No abstract available.

Cite
Hoshino K, Hayashi M, Ishizaki A, et al. Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Front Pediatr. 2021;9:569594doi: 10.3389/fped.2021.569594.
Hoshino, K., Hayashi, M., Ishizaki, A., Kimura, K., Kubota, M., Nezu, A., & Yasuhara, A. (2021). Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Frontiers in pediatrics, 9569594. https://doi.org/10.3389/fped.2021.569594
Hoshino, Kyoko, et al. "Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan." Frontiers in pediatrics vol. 9 (2021): 569594. doi: https://doi.org/10.3389/fped.2021.569594
Hoshino K, Hayashi M, Ishizaki A, Kimura K, Kubota M, Nezu A, Yasuhara A. Very-Low-Dose Levodopa Therapy for Pediatric Neurological Disorders: A Preliminary Questionnaire in Japan. Front Pediatr. 2021 Mar 04;9:569594. doi: 10.3389/fped.2021.569594. eCollection 2021. PMID: 33748036; PMCID: PMC7970027.
Copy Download .nbib Format: NLM
Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study.

Parkinson's disease

Zhou H, Li S, Yu H, Sun S, Wan X, Zhu X, Liu CF, Chen L, Xiang W, Sun Y, Chen H, Chen S.
PMID: 33763199
Parkinsons Dis. 2021 Mar 03;2021:8834950. doi: 10.1155/2021/8834950. eCollection 2021.

OBJECTIVE: To explore the efficacy and safety of pramipexole sustained release (SR) versus pramipexole immediate release (IR) in treating nocturnal symptoms in levodopa-treated Chinese patients with advanced Parkinson's disease (PD) and sleep disturbances.METHOD: SUSTAIN was an open-label, randomised, active-controlled...

Cite
Zhou H, Li S, Yu H, et al. Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study. Parkinsons Dis. 2021;2021:8834950doi: 10.1155/2021/8834950.
Zhou, H., Li, S., Yu, H., Sun, S., Wan, X., Zhu, X., Liu, C. F., Chen, L., Xiang, W., Sun, Y., Chen, H., & Chen, S. (2021). Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study. Parkinson's disease, 20218834950. https://doi.org/10.1155/2021/8834950
Zhou, Haiyan, et al. "Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study." Parkinson's disease vol. 2021 (2021): 8834950. doi: https://doi.org/10.1155/2021/8834950
Zhou H, Li S, Yu H, Sun S, Wan X, Zhu X, Liu CF, Chen L, Xiang W, Sun Y, Chen H, Chen S. Efficacy and Safety of Pramipexole Sustained Release versus Immediate Release Formulation for Nocturnal Symptoms in Chinese Patients with Advanced Parkinson's Disease: A Pilot Study. Parkinsons Dis. 2021 Mar 03;2021:8834950. doi: 10.1155/2021/8834950. eCollection 2021. PMID: 33763199; PMCID: PMC7946461.
Copy Download .nbib Format: NLM
SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.

Human genetics

Mir A, Almudhry M, Alghamdi F, Albaradie R, Ibrahim M, Aldurayhim F, Alhedaithy A, Alamr M, Bawazir M, Mohammad S, Abdelhay S, Bashir S, Housawi Y.
PMID: 34797406
Hum Genet. 2022 Jan;141(1):81-99. doi: 10.1007/s00439-021-02404-x. Epub 2021 Nov 19.

The uptake and efflux of solutes across a plasma membrane is controlled by transporters. There are two main superfamilies of transporters, adenosine 5'-triphosphate (ATP) binding cassettes (ABCs) and solute carriers (SLCs). In the brain, SLC transporters are involved in...

Cite
Mir A, Almudhry M, Alghamdi F, et al. SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population. Hum Genet. 2021;141(1):81-99doi: 10.1007/s00439-021-02404-x.
Mir, A., Almudhry, M., Alghamdi, F., Albaradie, R., Ibrahim, M., Aldurayhim, F., Alhedaithy, A., Alamr, M., Bawazir, M., Mohammad, S., Abdelhay, S., Bashir, S., & Housawi, Y. (2022). SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population. Human genetics, 141(1), 81-99. https://doi.org/10.1007/s00439-021-02404-x
Mir, Ali, et al. "SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population." Human genetics vol. 141,1 (2022): 81-99. doi: https://doi.org/10.1007/s00439-021-02404-x
Mir A, Almudhry M, Alghamdi F, Albaradie R, Ibrahim M, Aldurayhim F, Alhedaithy A, Alamr M, Bawazir M, Mohammad S, Abdelhay S, Bashir S, Housawi Y. SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population. Hum Genet. 2022 Jan;141(1):81-99. doi: 10.1007/s00439-021-02404-x. Epub 2021 Nov 19. PMID: 34797406.
Copy Download .nbib Format: NLM
Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis.

Medicine

Wang Y, Jiang DQ, Lu CS, Li MX, Jiang LL.
PMID: 34871213
Medicine (Baltimore). 2021 Nov 05;100(44):e27511. doi: 10.1097/MD.0000000000027511.

BACKGROUND: Pramipexole (P) or levodopa (L) treatment has been suggested as a therapeutic method for Parkinson disease (PD) in many clinical studies. Nonetheless, the combined effects of 2 drugs for PD patients are not completely understood.The aim of this...

Cite
Wang Y, Jiang DQ, Lu CS, et al. Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(44):e27511doi: 10.1097/MD.0000000000027511.
Wang, Y., Jiang, D. Q., Lu, C. S., Li, M. X., & Jiang, L. L. (2021). Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis. Medicine, 100(44), e27511. https://doi.org/10.1097/MD.0000000000027511
Wang, Yan, et al. "Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis." Medicine vol. 100,44 (2021): e27511. doi: https://doi.org/10.1097/MD.0000000000027511
Wang Y, Jiang DQ, Lu CS, Li MX, Jiang LL. Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis. Medicine (Baltimore). 2021 Nov 05;100(44):e27511. doi: 10.1097/MD.0000000000027511. PMID: 34871213; PMCID: PMC8568447.
Copy Download .nbib Format: NLM
Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility.

Neurology. Clinical practice

Khoshbin K, Hassan A, Camilleri M.
PMID: 34484938
Neurol Clin Pract. 2021 Aug;11(4):e407-e413. doi: 10.1212/CPJ.0000000000001003.

OBJECTIVE: To evaluate gastric emptying (GE) and colonic transit in a cohort of patients with Parkinson disease and other parkinsonism disorders and to determine whether abnormal gut transit precedes motor onset of parkinsonism.METHODS: Medical record review of 84 patients...

Cite
Khoshbin K, Hassan A, Camilleri M. Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility. Neurol Clin Pract. 2021;11(4):e407-e413doi: 10.1212/CPJ.0000000000001003.
Khoshbin, K., Hassan, A., & Camilleri, M. (2021). Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility. Neurology. Clinical practice, 11(4), e407-e413. https://doi.org/10.1212/CPJ.0000000000001003
Khoshbin, Katayoun, et al. "Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility." Neurology. Clinical practice vol. 11,4 (2021): e407-e413. doi: https://doi.org/10.1212/CPJ.0000000000001003
Khoshbin K, Hassan A, Camilleri M. Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility. Neurol Clin Pract. 2021 Aug;11(4):e407-e413. doi: 10.1212/CPJ.0000000000001003. PMID: 34484938; PMCID: PMC8382402.
Copy Download .nbib Format: NLM
Showing 1525 to 1530 of 1530 entries